SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001604488-24-000031
Filing Date
2024-02-12
Accepted
2024-02-12 17:32:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 schedule13gaflag021224.htm SC 13G/A 77922
  Complete submission text file 0001604488-24-000031.txt   79780
Mailing Address 225 W. WACKER DRIVE 21ST FLOOR CHICAGO IL 60606
Business Address 225 W. WACKER DRIVE 21ST FLOOR CHICAGO IL 60606 872-260-4182
First Trust Capital Management L.P. (Filed by) CIK: 0001604488 (see all company filings)

IRS No.: 901006997 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Subject) CIK: 0001855485 (see all company filings)

IRS No.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92875 | Film No.: 24621516
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)